Zura Bio Ltd (94E)

Currency in EUR
3.3400
-0.1200(-3.47%)
Delayed Data·
94E is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.34003.3400
52 wk Range
2.84006.0000
Key Statistics
Bid/Ask
3.50 / 3.60
Prev. Close
3.46
Open
3.34
Day's Range
3.34-3.34
52 wk Range
2.84-6
Volume
-
Average Volume (3m)
813
1-Year Change
16.7832%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
94E Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Zura Bio Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Aug 11, 2026
EPS / Forecast
-0.21 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

94E Income Statement

Compare 94E to Peers and Sector

Metrics to compare
94E
Peers
Sector
Relationship
P/E Ratio
−3.1x−8.2x−0.3x
PEG Ratio
0.060.130.00
Price/Book
1.9x3.7x2.6x
Price / LTM Sales
-11.7x2.9x
Upside (Analyst Target)
-153.9%62.0%
Fair Value Upside
Unlock−4.9%9.5%Unlock

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
7.11M7.42%24.61M
Other Institutional Investors
106.68M92.58%369.12M
Public Companies & Retail Investors
0.000.00%0.00
Total
113.8M100.00%393.73M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Athanor Capital, LP12.09%11,581,40240,072
Montanova Capital, LLC9.85%9,443,00132,673

People Also Watch

775.20
ARGX
+6.22%
124.83
HALO
+1.90%
0.3375
COSM
+3.85%
68.16
CDNA
+1.60%
19.840
AMRX
+2.48%

FAQ

What Is the Zura Bio (94E) Stock Price Today?

The Zura Bio stock price today is 3.3400 EUR.

What Stock Exchange Does Zura Bio Trade On?

Zura Bio is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for Zura Bio?

The stock symbol for Zura Bio is "94E."

What Is the Zura Bio Market Cap?

As of today, Zura Bio market cap is 325.5800M EUR.

What Is Zura Bio's Earnings Per Share (TTM)?

The Zura Bio EPS (TTM) is -0.95.

From a Technical Analysis Perspective, Is 94E a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Zura Bio Stock Split?

Zura Bio has split 0 times.

How Many Employees Does Zura Bio Have?

Zura Bio has 40 employees.

What is the current trading status of Zura Bio (94E)?

As of Oct 20, 2026, Zura Bio (94E) is trading at a price of 3.3400 EUR, with a previous close of 3.4600 EUR. The stock has fluctuated within a day range of 3.3400 EUR to 3.3400 EUR, while its 52-week range spans from 2.8400 EUR to 6.0000 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.